NICE guidance on radium-223 dichloride for hormone-relapsed prostate cancer with bone metastases

Lancet Oncol. 2016 Mar;17(3):275-6. doi: 10.1016/S1470-2045(16)00060-7. Epub 2016 Jan 27.
No abstract available

Publication types

  • News

MeSH terms

  • Aged
  • Bone Neoplasms / mortality
  • Bone Neoplasms / secondary*
  • Bone Neoplasms / therapy*
  • Disease-Free Survival
  • Humans
  • Male
  • Middle Aged
  • Neoplasm Recurrence, Local / mortality
  • Neoplasm Recurrence, Local / pathology
  • Neoplasm Recurrence, Local / therapy
  • Practice Guidelines as Topic*
  • Prognosis
  • Prostatic Neoplasms, Castration-Resistant / mortality
  • Prostatic Neoplasms, Castration-Resistant / pathology*
  • Prostatic Neoplasms, Castration-Resistant / therapy*
  • Radioisotopes
  • Radium*
  • Risk Assessment
  • Survival Rate
  • Treatment Outcome
  • United Kingdom

Substances

  • Radioisotopes
  • radium Ra 223 dichloride
  • Radium